dcSSc
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin for Systemic Sclerosis (NCT03222492) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-09-20 |
Track dcSSc automatically
Every clearance here is in the API, with alerts when new ones post.